Literature DB >> 9918540

Hepatic disposition of the acyl glucuronide1-O-gemfibrozil-beta-D-glucuronide: effects of dibromosulfophthalein on membrane transport and aglycone formation.

L Sabordo1, B C Sallustio, A M Evans, R L Nation.   

Abstract

The liver plays an important role in the disposition of acyl glucuronides by determining their extent of formation, biliary excretion, and efflux into blood. Thus, both intrahepatic and extrahepatic exposure to these reactive polar conjugates depends on the efficiency of hepatic transport mechanisms, which may be shared with other nonbile acid organic anions. Using the isolated perfused rat liver preparation, the hepatic disposition of the acyl glucuronide, 1-O-gemfibrozil-beta-D-glucuronide, was examined in the presence of the organic anion dibromosulfophthalein (DBSP). Using a recirculating system, livers were perfused for 90 min with an erythrocyte-free perfusion medium containing 1% (w/v) albumin and 1-O-gemfibrozil-beta-D-glucuronide (3 microM) alone (n = 6) or with DBSP (200 microM, n = 7). The glucuronide was avidly taken up by the liver, excreted into bile, and hydrolyzed within the liver to its aglycone, gemfibrozil. DBSP significantly (P <.05) lowered the conjugate's mean hepatic clearance (8.98-5.17 ml/min), intrinsic clearance (44.0-17.7 ml/min), and fraction eliminated in bile (72. 8-48.7% of the dose), while increasing perfusate gemfibrozil concentrations (0.52-0.92 microM at 90 min). Furthermore, DBSP significantly (P <.05) lowered the ratio of intrahepatic to unbound perfusate concentrations of 1-O-gemfibrozil-beta-D-glucuronide (139. 0-35.0) and showed a trend to lower the ratio of bile to intrahepatic concentrations (111.3-76.2, P =.05). Thus, the study demonstrated that DBSP inhibited both the sinusoidal uptake and canalicular transport of 1-O-gemfibrozil-beta-D-glucuronide, suggesting that the hepatic membrane transport of acyl glucuronides is carrier mediated and shared with other organic anions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918540

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide.

Authors:  Mikko Niemi; Janne T Backman; Laura Juntti-Patinen; Mikko Neuvonen; Pertti J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

2.  Self-micellization of gemfibrozil 1-O-beta acyl glucuronide in aqueous solution.

Authors:  David M Shackleford; Richard J Prankerd; Martin J Scanlon; William N Charman
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

3.  Effects of dose, flow rate, and bile acid on diclofenac disposition in the perfused rat liver.

Authors:  Misato Uraki; Atsushi Kawase; Yuka Matsushima; Masahiro Iwaki
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-02-06       Impact factor: 2.441

4.  Stereoselective hepatic disposition of model diastereomeric acyl glucuronides.

Authors:  David M Shackleford; Roger L Nation; R W Milne; P J Hayball; Allan M Evans
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-02       Impact factor: 2.745

5.  Multiple inhibition mechanisms and prediction of drug-drug interactions: status of metabolism and transporter models as exemplified by gemfibrozil-drug interactions.

Authors:  Laura K Hinton; Aleksandra Galetin; J Brian Houston
Journal:  Pharm Res       Date:  2007-09-27       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.